Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis

被引:12
|
作者
Soni, Anisha [1 ]
Thiyagarajan, Arun [1 ]
Reeve, Joanne [2 ]
机构
[1] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
[2] Acad Primary Care, Hull York Med Sch, Kingston Upon Hull, N Humberside, England
关键词
Benzodiazepines; deprescribing; meta-analysis; primary care; systematic review; Z-drugs; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED-TRIAL; OLDER; DISCONTINUATION; WITHDRAWAL; ADULTS;
D O I
10.1111/add.15997
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and Aims A total of 2.4 million adults in England were dispensed a benzodiazepine or Z-drug (BZRA) in 2017/18, and more than 250 000 patients in the UK take BZRAs beyond the recommended duration. Deprescribing is a clinician-guided process of withdrawing inappropriate drugs. This review aimed to evaluate the evidence base supporting the feasibility and clinical effectiveness of all forms of deprescribing initiatives used to discontinue long-term (>= 4 weeks) BZRAs. Method Systematic review of randomized controlled trials evaluating BZRAs deprescribing among adults in community, primary or outpatient settings. MEDLINE, Embase and PsycINFO were searched from inception to February 2021. Primary outcomes were successful discontinuation in the short (< 4 weeks) or long term (>= 4 weeks) and the occurrence of withdrawal symptoms, behavioural or psychological symptoms. Studies were categorized as pharmacological or non-pharmacological supported interventions. Study quality was assessed using the Cochrane risk-of-bias tool. Where appropriate, risk ratios (RRs), mean differences and 95% confidence intervals (CIs) were calculated, and Mantel-Haenszel methods using the random-effect meta-analysis was undertaken to calculate summary effect estimates. Results Ten studies were included (n = 1431 participants). Heterogeneity in study design and effect was observed. Benzodiazepines were successfully deprescribed when gradually tapered with non-pharmacological support compared with gradual tapering alone in the short term (n = 124; RR = 2.02; 95% CI = 1.41, 2.89) and long term (n = 123; RR = 2.45; 95% CI = 1.56, 3.85). Benzodiazepine deprescribing was more successful when supported by non-pharmacological methods versus routine care (n = 189; RR = 3.26; 95% CI = 2.36, 4.51). Quality of evidence reporting effectiveness was very low to low. Conclusions It may be feasible to deprescribe benzodiazepines depending on the process and support mechanisms employed.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [1] Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis
    Donnelly, Karen
    Bracchi, Robert
    Hewitt, Jonathan
    Routledge, Philip A.
    Carter, Ben
    PLOS ONE, 2017, 12 (04):
  • [2] The Acute Cognitive Effects of the Z-drugs: A Systematic Review and Meta-Analysis
    Stranks, E.
    Crowe, S.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2013, 28 (06) : 530 - 530
  • [4] Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
    Pollmann, Andre S.
    Murphy, Andrea L.
    Bergman, Joel C.
    Gardner, David M.
    BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
  • [5] Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
    André S. Pollmann
    Andrea L. Murphy
    Joel C. Bergman
    David M. Gardner
    BMC Pharmacology and Toxicology, 16
  • [6] The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
    Hodson, Nathan
    BJPSYCH BULLETIN, 2024,
  • [7] The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
    Gordon, Sian
    BRITISH JOURNAL OF GENERAL PRACTICE, 2024, 74 (745): : 369 - 370
  • [8] Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital
    Shilpa, Halumatha Surendra Shree
    Kumar, N. Naveen
    Maheswari, Eswaran
    Virupaksha, Harave Shanmugam
    Subeesh, Viswam
    Saraswathy, Ganesan Rajalekshmi
    Kunnavil, Radhika
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 44 : 189 - 194
  • [9] Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis
    Treves, Nir
    Perlman, Amichai
    Geron, Lital Kolenberg
    Asaly, Angham
    Matok, Ilan
    AGE AND AGEING, 2018, 47 (02) : 201 - 208
  • [10] Misuse of benzodiazepines and Z-drugs in the UK
    Kapil, V.
    Green, J. L.
    Le Lait, C.
    Wood, D. M.
    Dargan, P. I.
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (05) : 407 - 408